Sandoz Group AG logo

Sandoz Group AG

SDZ.SW
HealthcareSIXSwitzerland
59.56CHF-0.10 (-0.17%)

About Sandoz

Sandoz Group AG develops, manufactures, markets generic pharmaceuticals and biosimilars worldwide.

The company supplies both finished dosage forms and active pharmaceutical ingredients (APIs) to healthcare providers and industry partners.

  • Generic Pharmaceuticals: Finished dosage forms of small molecule drugs supplied to third parties across a wide range of therapeutic areas

  • Biosimilars: Protein- or biotechnology-based products that serve as affordable alternatives to reference biologics

  • Biotechnology Services: Contract manufacturing and development services for complex biologic medicines

  • Anti-infectives: APIs and intermediates, primarily antibiotics used in treating bacterial infections

Sandoz was founded in 1886 and is headquartered in Rotkreuz, Switzerland.

Sandoz's Business Strategy

​Sandoz Group AG’s business strategy is centered on delivering high-quality, affordable medicines through its dual focus on generics and biosimilars. As a standalone company since its spin-off from Novartis in October 2023, Sandoz aims to leverage its global leadership to expand access to essential treatments…

Available on Finplify

Free account required

Sign up free

Our Take on Sandoz

Pros:

Generics & Biosimilars Position: Sandoz is one of the world’s largest producers of generic drugs and biosimilars, providing affordable alternatives to branded medicines (patent). Its broad product portfolio and global reach support volume-driven revenue stability.

Europe & Emerging Markets Presence: The company has…

Available on Finplify

Free account required

Sign up free

Company Details

Exchange
SIX
Country
Switzerland
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Richard Saynor
Employees
22,049
IPO Date
2023-10-03
ISIN
CH1243598427
Website
sandoz.com

Key Metrics

Market Cap
25.77BCHF
P/E Ratio (TTM)
35.47
Net Profit Margin
8.22%
Debt / Asset Ratio
0.26
Dividend Yield (TTM)
1.01%
Volume
159,611
Avg Volume
787,086
Shares Outstanding
430.70M
Free Float
96.20%
β Beta
0.33
52W Range
26.3 - 72.7

Fundamental Analysis

Proprietary 5-category scoring system

Score Fingerprint

Section Scores

Profitability
2.9/5Average
Liquidity
3.0/5Average
Leverage
4.0/5Good
Cash Flow
5.0/5Excellent
Valuation
3.1/5Average

Full Breakdown & Peer Ranking

See the detailed score for every metric and how this stock ranks against its sector peers

Unlock for free
Free to join

Unlock the full research on Sandoz

Get the full fundamental score breakdown, business strategy, our investment take, live charts and AI-powered briefings. All in one ad-free workspace.

300+ Curated Stocks

A hand-picked universe of world-class businesses across every major market and sector.

AI Analyst Briefings

Deploy your own AI analyst that monitors your portfolio and delivers daily intelligence reports.

Proprietary Fundamentals

Five-category scoring for every stock — profitability, liquidity, leverage, cash flow, and valuation.